Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03724331 · ClinicalTrials.gov registry record · NA
Understanding the Post-Surgical Non-Small Cell Lung Cancer Patient's Symptom Experience
A NA study, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 235
- Enrollment target
NCT03724331: Completed NA study, sponsored by University of Nebraska.
NCT03724331 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 235 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03724331, a NA study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 235 participants
- Enrollment target
Study Summary
Among 13 core symptoms across 3,106 breast, colorectal, prostate, and lung cancer patients, persons with lung cancer were the most symptomatic, with moderate to severe fatigue being reported with the greatest prevalence. This is a proposed randomized controlled trial of a novel rehabilitative intervention for persons with non-small cell lung cancer after surgery that promotes self-management of cancer-related fatigue (CRF) and is practical, portable, low cost, and safe. The results of the study will provide a novel exercise intervention, and its optimal timing, that helps a vulnerable population by reducing CRF severity and fatigability and is applicable to nearly all post-thoracotomy lung cancer patients.
Primary Outcome
The Brief Fatigue Inventory measured the degree of cancer-related fatigue severity on an 11-point scale (0-10, 10 = most severe)
Interventions
- BEHAVIORAL Light Physical Activity 1
- BEHAVIORAL Light Physical Activity 2
- BEHAVIORAL Support Education Activity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 235 participants |
| Start Date | 2019-06-04 |
| Est. Completion | 2023-11-01 |
| Phase | NA |
What the finished NCT03724331 record still lists
NCT03724331 is an interventional study that assigns participants to a tested intervention. The registered 235 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 3 interventions - of which Light Physical Activity 1 is the first listed.
NCT03724331 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03724331 about?
NCT03724331 is a clinical study titled "Understanding the Post-Surgical Non-Small Cell Lung Cancer Patient's Symptom Experience". Among 13 core symptoms across 3,106 breast, colorectal, prostate, and lung cancer patients, persons with lung cancer were the most symptomatic, with moderate to severe fatigue being reported with the greatest prevalence. This is a proposed randomized controlled trial of a novel rehabilitative interv...
What is the current status of trial NCT03724331?
This trial is currently completed. It is a NA study. The enrollment target is 235 participants. The study started on 2019-06-04. Estimated completion is 2023-11-01.
What interventions are being tested in trial NCT03724331?
The interventions under investigation include: Light Physical Activity 1 (BEHAVIORAL), Light Physical Activity 2 (BEHAVIORAL), Support Education Activity (BEHAVIORAL).
Who is sponsoring clinical trial NCT03724331?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03724331's enrollment target sits among peer trials
235 461st of 2000 higher than 1,539 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01524211 · 235 participants · NA
Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms
- NCT05316155 · 235 participants · Phase 1
Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer
- NCT05353569 · 235 participants · NA
Coherent Optical Detection of Middle Ear Disease
- NCT05390918 · 235 participants · NA
Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI